Prof dr med michael hallekirk

Med dr md

Prof.
prof dr med michael hallekirk

Prof dr med michael hallekirk

Our research is focused on identifying new pathways with relevance for the pathogenesis of CLL. To pursue this aim, we employ in vitro biochemical assays, as well as genetically engineered .

Prof dr med michael hallekirk md

Martin Dreyling Professor of Medicine, University of Munich Verified email at
Prof dr med michael hallekirk hospital
Michael Hallek's research works with 6, citations and 8, reads, including: The proto-oncogene TCL1A deregulates cell cycle and genomic stability in CLL.